|
Thrombin
Citations 11-20 of 60 total displayed.
|
Past content
(since Nov 2000):
|
- Articles
Hemodynamic Modulation of Endocardial Thromboresistance
- Navin K. Kapur, Clayton B. Deming, Sunil Kapur, Ce Bian, Hunter C. Champion, J. Kevin Donahue, David A. Kass, and Jeffrey J. Rade
Circulation published December 26, 2006, doi:10.1161/CIRCULATIONAHA.106.640698
[Abstract]
- Vascular Medicine
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation 2006;114:2490-2497; published online before print as doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
[Full text]
- Articles
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology. A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation published November 13, 2006, doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
- Vascular Medicine
Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans
- Ingibjörg J. Gudmundsdóttir, Ian L. Megson, Jillian S. Kell, Christopher A. Ludlam, Keith A.A. Fox, David J. Webb, and David E. Newby
Circulation 2006;114:1625-1632; published online before print as doi:10.1161/CIRCULATIONAHA.106.638478
[Abstract]
[Full text]
- Articles
Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans
- Ingibjörg J. Gudmundsdóttir, Ian L. Megson, Jillian S. Kell, Christopher A. Ludlam, Keith A.A. Fox, David J. Webb, and David E. Newby
Circulation published October 2, 2006, doi:10.1161/CIRCULATIONAHA.106.638478
[Abstract]
- Basic Science for Clinicians
Protease-Activated Receptors in Cardiovascular Diseases
- Andrew J. Leger, Lidija Covic, and Athan Kuliopulos
Circulation 2006;114:1070-1077, doi:10.1161/CIRCULATIONAHA.105.574830
[Abstract]
[Full text]
- Vascular Medicine
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
- Andrew J. Leger, Suzanne L. Jacques, Jehangir Badar, Nicole C. Kaneider, Claudia K. Derian, Patricia Andrade-Gordon, Lidija Covic, and Athan Kuliopulos
Circulation 2006;113:1244-1254; published online before print as doi:10.1161/CIRCULATIONAHA.105.587758
[Abstract]
[Full text]
- Articles
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
- Andrew J. Leger, Suzanne L. Jacques, Jehangir Badar, Nicole C. Kaneider, Claudia K. Derian, Patricia Andrade-Gordon, Lidija Covic, and Athan Kuliopulos
Circulation published February 27, 2006, doi:10.1161/CIRCULATIONAHA.105.587758
[Abstract]
- Vascular Medicine
Homozygosity for Factor V Leiden Leads to Enhanced Thrombosis and Atherosclerosis in Mice
- Daniel T. Eitzman, Randal J. Westrick, Yuechun Shen, Peter F. Bodary, Shufang Gu, Sara L. Manning, Sarah L. Dobies, and David Ginsburg
Circulation 2005;111:1822-1825; published online before print as doi:10.1161/01.CIR.0000160854.75779.E8
[Abstract]
[Full text]
- Articles
Homozygosity for Factor V Leiden Leads to Enhanced Thrombosis and Atherosclerosis in Mice
- Daniel T. Eitzman, Randal J. Westrick, Yuechun Shen, Peter F. Bodary, Shufang Gu, Sara L. Manning, Sarah L. Dobies, and David Ginsburg
Circulation published April 4, 2005, doi:10.1161/01.CIR.0000160854.75779.E8
[Abstract]
|
|
